| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
* From the Department of Medicine, Division of Cardiology, Hamilton General Hospital Site; and the
Department of Anesthesiology, McMaster University, Hamilton, Ontario, Canada.
Address correspondence to: Dr. Jon-David Schwalm, Hamilton Health Sciences - McMaster University, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada. Phone: 905-317-0135; Fax: 905-527-1914; E-mail: schwalj{at}mcmaster.ca
Purpose: Nasal septoplasty is a surgical procedure offered to patients with chronic snoring secondary to nasal obstruction. We describe a case of cardiogenic shock following the administration of metoprolol to treat hypertension, (likely) induced by systemic absorption of topical epinephrine used during a routine nasal septoplasty.
Clinical features: A 29-yr-old male, with no significant medical history, was scheduled for nasal septoplasty for mild nasal obstruction. Following routine anesthetic induction, cotton balls, soaked with epinephrine (1:1000), were applied to the nasal mucosa. The patient became hypertensive with a blood pressure of 207/123 mmHg. Intravenous metoprolol was administered. Severe pulmonary edema ensued, with resulting hypoxic respiratory failure and cardiogenic shock. The patient was transferred to a tertiary care facility for percutaneous cardiopulmonary bypass. After five days of cardiopulmonary bypass support and six weeks of intensive care monitoring, the patient’s cardiac status returned to normal limits.
Conclusion: A hypertensive response, following systemically absorbed topical vasoconstrictors, including both phenylephrine and epinephrine, can be associated with dire consequences when treated with a beta-adrenergic blocking drug and, possibly, calcium channel blockers. To prevent severe complications including; pulmonary edema, cardiogenic shock, cardiac arrest, and, possibly, death, these drug interactions need to be appreciated.
1 Kalyanaraman M, Carpenter RL, McGlew MJ, Guertin SR. Cardiopulmonary compromise after use of topical and submucosal alpha-agonists: possible added complication by the use of beta-blocker therapy. Otolaryngol Head Neck Surg 1997; 117: 56–61.[Medline]
2 Groudine SB, Holliger I, Jones J, DeBouno BA. New York State guidelines on the topical use of phenylephrine in the operating room. Anesthesiology 2000; 92: 859–64.[Medline]
3 Massie BM, Shah NB. Evolving trends in epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133: 703–12.[Medline]
4 Wolff B, Machill K, Schulzki I, Schumacher D, Werner D. Acute reversible cardiomyopathy with cardiogenic shock in a patient with Addisonian crisis: a case report. Int J Cardial 2007; 116: e71–3.
5 Olsen SW, Deal LE, Piesman M. Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and profound hypocalcemia. Ann Intern Med 2004; 140: 849–51.
6 Kaye J, Edlin S, Thompson I, Leedma PJ. Pheochromocytoma presenting as life-threatening pulmonary edema. Endocrine 2001; 15: 203–4.[Medline]
7 McCarthy RE 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690–5.
8 Singh PP, Dimich I, Shamsi A. Intraoperative pulmonary oedema in a young cocaine smoker. Can J Anaesth 1994; 41: 961–4.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
